[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367465-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367465-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","metabolic-changes-in-neuroendocrine-neoplasms-review","Metabolic changes in neuroendocrine neoplasms - Review","","Neuroendocrine neoplasms (NENs) are a highly heterogeneous class of tumors arising from neuroendocrine cells, with incidence increasing over time. Metabolic alteration is widely used as a marker of tumor progression in other malignancies, yet it remains comparatively underexplored and lacks comprehensive systematic reviews in NENs. This review synthesizes evidence linking metabolic changes in glucose, lipid, metabolic syndrome, amino acids, and metabolomics, and evaluates potential metabolic-change–based therapeutic strategies for NENs.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/metabolic-changes-in-neuroendocrine-neoplasms-review/367465/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/metabolic-changes-in-neuroendocrine-neoplasms-review/367465.png","ImageObject",300,407,{"name":42,"@type":43},"Riley West","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the review focus on regarding neuroendocrine neoplasms (NENs)?","Question",{"text":63,"@type":64},"It reviews the relationship between metabolic changes and NENs across glucose metabolism, lipid metabolism, metabolic syndrome, amino acid metabolism, and metabolomics.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why are metabolic changes important in tumor progression, and how is this handled for NENs?",{"text":68,"@type":64},"Metabolic change is a recognized marker of progression in many cancers, but in NENs it is relatively poorly studied and systematic reviews have been lacking, motivating this synthesis.",{"name":70,"@type":61,"acceptedAnswer":71},"How can metabolic changes in NENs potentially guide therapy?",{"text":72,"@type":64},"The review discusses potential therapeutic strategies that target or leverage metabolic changes associated with NENs.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367465,1790536016,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099523885074,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Cellular and Molecular Life Sciences (2025) 82:205  \n[https://doi.org/10.1007/s00018-025-05656-2](https://doi.org/10.1007/s00018-025-05656-2) Cellular and Molecular Life Sciences  \nREVIEW  \nMetabolic changes in neuroendocrine neoplasms  \nChunhua Hu1,2 · Lingyi Chen2 · Yi Ding2 · MujieYe2 · Qiyun Tang2  \nReceived: 12 November 2024 / Revised: 5 February 2025 / Accepted: 11 March 2025 © The Author(s) 2025  \nAbstract  \nNeuroendocrine neoplasms (NENs) are a group of highly heterogeneous neoplasms originating from neuroendocrine cells with a gradually increased incidence. Metabolic change is one of the recognized markers of tumor progression, which has been extensively and systematically studied in other malignant tumors. However, metabolic change in NENs has been relatively poorly studied, and systematic reviews are lacking. We reviewed the relationship between metabolic changes and NENs from the aspects of glucose metabolism, lipid metabolism, metabolic syndrome, amino acid metabolism and metabolomics, and discussed the potential therapeutic strategies of metabolic changes for NENs.  \nKeywords Neuroendocrine neoplasm · Metabolic changes · Metabolite  \nIntroduction  \nNeuroendocrine neoplasms (NENs) are a highly heterogeneous group of tumors that originate from peptidergic neurons and neuroendocrine cells found throughout the body, including the gastrointestinal tract, lungs, pancreas, and other less common locations like the adrenal glands and thymus [1] . Among these, gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are the most prevalent [2, 3] . Gastric NENs are relatively uncommon and can be  \n\n| Chunhua Hu, Lingyi Chen and Yi Ding contributed equally to this work. |\n| --- |\n| One sentence summary: We reviewed the relationship between metabolic changes and neuroendocrine neoplasms, and discussed the potential therapeutic strategies. |\n\n􀀍 MujieYe [mujiey0629@163.com](mujiey0629@163.com)  \n􀀍 Qiyun Tang [qytang@njmu.edu.cn](qytang@njmu.edu.cn)  \n1 Shanghai Key Laboratory of Gut Microecology and Associated Major Diseases Research, Digestive Disease Research and Clinical Translation Center, Department of Gastroenterology, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China  \n2 Neuroendocrine Tumor Diagnosis and Treatment Center, Jiangsu Province Hospital, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China  \neither sporadic or associated with hereditary syndromes like Multiple Endocrine Neoplasia Type 1 (MEN1) [4] . Small intestinal NENs, particularly those arising in the ileum, are among the most frequent types of gastrointestinal NENs. Rectal NENs are usually small and well-differentiated, often discovered incidentally during routine colonoscopies. Pancreatic NENs (pNENs) can be functioning or non-functioning, depending on whether they secrete hormones that cause clinical symptoms. Common types include insulinomas, gastrinomas, and glucagonomas, each named for the hormone they overproduce [2, 5] .  \nNENs was previously considered to be a rare disease, but the incidence of NENs has increased in recent decades, due to heightened health awareness, the expanded use of endoscopy, and advancements in diagnostic imaging techniques within nuclear medicine. According to the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database, the incidence rate of NENs has been steadily climbing. The SEER database reveals that the current annual incidence rate stands at 8.4 per 100,000 individuals, marking an increase of nearly 8 times from 1973 (1.09 per 100 000) . The increase occurred across all sites, stages, and grades. This growth rate significantly outpaces that of other malignancies, highlighting NENs as a grave threat to human life and health [6–9] .  \nNeuroendocrine neoplasms (NENs) can be categorized into functional NENs and non-functional NENs. Functional NENs are characterized by their secretion of peptides oramine hormones,","cbCaioIarg5aXreA","https://ap.wps.com/l/cbCaioIarg5aXreA","pdf",2315098,14,"English","# Introduction\n## Metabolic changes and tumor progression\n## Metabolic pathways in NENs\n# Clinical categorization of NENs\n## Functional vs non-functional NENs\n## Paraneoplastic syndromes and tumor biology\n# Metabolic regulation and signaling (examples)","[{\"question\":\"What does the review focus on regarding neuroendocrine neoplasms (NENs)?\",\"answer\":\"It reviews the relationship between metabolic changes and NENs across glucose metabolism, lipid metabolism, metabolic syndrome, amino acid metabolism, and metabolomics.\"},{\"question\":\"Why are metabolic changes important in tumor progression, and how is this handled for NENs?\",\"answer\":\"Metabolic change is a recognized marker of progression in many cancers, but in NENs it is relatively poorly studied and systematic reviews have been lacking, motivating this synthesis.\"},{\"question\":\"How can metabolic changes in NENs potentially guide therapy?\",\"answer\":\"The review discusses potential therapeutic strategies that target or leverage metabolic changes associated with NENs.\"}]","Metabolic changes in neuroendocrine neoplasms - Review | PDF",1790170896,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c7bcceb8e46914550f453f27e1b60f6.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a536bf73726357ac384614f6e6c51055.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/823bc828e021fee4238c3effc506b82d.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db459740dab3afacec7d4171e2946368.webp",980,1301]